News

October 23, 2008

Arginetix, Inc. Completes $2.3 Million Initial Financing and Technology License

October 8, 2008

FDA Clears Neurostar® TMS Therapy for the Treatment of Depression

October 7, 2008

Neotropix® Announces Expansion of On-going Clinical Trial for Adult Neuroendocrine Cancers

October 6, 2008

Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C

October 6, 2008

Biolex Therapeutics Enters Into Agreement to Acquire Full Locteron® Commercial Rights

October 1, 2008

Tranzyme Pharma Announces Positive Phase IIb Results with Its Ghrelin Agonist, TZP-101, for Postoperative Ileus (POI)

September 30, 2008

Dow Jones Venture Wire: Oceana To Capture Spirit Of Esprit, ESP With Series A Financing

August 1, 2008

EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene® I.V.

July/August 2008

PharmaVOICE: PharmaVOICE 100 Profiles EKR co-founder and CEO

July 21, 2008

BioWorld Today: Diasome Changes up Insulin Treatments in Diabetes Field

June 17, 2008

Tranzyme Pharma’s Ghrelin Agonist TZP-102 Demonstrates Safety and High Oral Bioavailability in the Successful Completion of a Phase I Trial

June 13, 2008

Transave Announces Positive Phase II Results for Once-daily Arikace™ in the Treatment of Cystic Fibrosis Patients who ave Pseudomonas Lung Infections

June 3, 2008

Protez Pharmaceuticals to be Acquired by Novartis for up to $400 million in cash

April 15, 2008

BioWorld Today: Diasome Pharmaceuticals Series B Financing Announcement

April 1, 2008

Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment

March 31, 2008

Study Confirms Anti-infective Arikace™ Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients.

March 31, 2008

Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing

March 10, 2008

Philadelphia Inquirer: Philly VCs back Jersey drug seller EKR

March 10, 2008

Argolyn Bioscience Grows Management Team

March 10, 2008

EKR Therapeutics Raises Over $145 Million in Support of Growth

February 27, 2008

Tengion Appoints Jeff Randall to Board of Directors

February 12, 2008

Nitric BioTherapeutics Hires Joel Lippman, M.D. as GM of Its Antimicrobial Business

January 29, 2008

Tranzyme Pharma Receives IND Clearance for Its Oral Ghrelin Agonist, TZP-102, for the Treatment of Gastroparesis

January 11, 2008

Nucleonics Initiates Hepatitis B Clinical Trial with Expressed Interfering RNA Therapeutic

January 3, 2008

Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder

January 2008

The Scientist, Philadelphia Supplement: Investment Momentum Building